Differentiation of Pseudomonas aeruginosa pili based on sequence and B-cell epitope analyses
- PMID: 7507890
- PMCID: PMC186117
- DOI: 10.1128/iai.62.2.371-376.1994
Differentiation of Pseudomonas aeruginosa pili based on sequence and B-cell epitope analyses
Abstract
The nucleotide sequences of three previously undescribed Pseudomonas aeruginosa pilin structural genes are presented. Comparisons of deduced pilin primary structure and flanking DNA sequence allowed placement of these and six previously published sequences into one of two groups. Epitope mapping, using overlapping immobilized peptides representing the pilin primary structure, with antipilin monoclonal antibodies revealed several B-cell determinants grouped near the carboxyl terminus of P. aeruginosa 1244 pilin. One determinant was found to reside near the pilin constant region. These determinants were found associated with the pili of 31 of 95 P. aeruginosa clinical isolates.
Similar articles
-
Cloning and sequencing of the Pseudomonas aeruginosa 1244 pilin structural gene.Mol Gen Genet. 1989 Mar;216(1):75-80. doi: 10.1007/BF00332233. Mol Gen Genet. 1989. PMID: 2499765
-
Serial isolates of Pseudomonas aeruginosa from a cystic fibrosis patient have identical pilin sequences.Infect Immun. 1988 Mar;56(3):665-72. doi: 10.1128/iai.56.3.665-672.1988. Infect Immun. 1988. PMID: 2893774 Free PMC article.
-
Characterization of the pilin gene of Moraxella bovis Dalton 2d and expression of pili from M. bovis in Pseudomonas aeruginosa.Infect Immun. 1990 Jun;58(6):1678-84. doi: 10.1128/iai.58.6.1678-1684.1990. Infect Immun. 1990. PMID: 1971258 Free PMC article.
-
The type-4 pilus is the major virulence-associated adhesin of Pseudomonas aeruginosa--a review.Gene. 1997 Jun 11;192(1):99-108. doi: 10.1016/s0378-1119(97)00116-9. Gene. 1997. PMID: 9224879 Review.
-
Pseudomonas aeruginosa antigens as potential vaccines.FEMS Microbiol Rev. 1997 Nov;21(3):243-77. doi: 10.1111/j.1574-6976.1997.tb00353.x. FEMS Microbiol Rev. 1997. PMID: 9451816 Review.
Cited by
-
Recent developments for Pseudomonas vaccines.Hum Vaccin. 2011 Oct;7(10):999-1011. doi: 10.4161/hv.7.10.16369. Epub 2011 Oct 1. Hum Vaccin. 2011. PMID: 21941090 Free PMC article. Review.
-
Identification of the Pseudomonas aeruginosa 1244 pilin glycosylation site.Infect Immun. 2002 Jun;70(6):2837-45. doi: 10.1128/IAI.70.6.2837-2845.2002. Infect Immun. 2002. PMID: 12010970 Free PMC article.
-
Functional consequences of sequence variation in bundlin, the enteropathogenic Escherichia coli type IV pilin protein.Infect Immun. 2007 Oct;75(10):4687-96. doi: 10.1128/IAI.00009-07. Epub 2007 Jul 16. Infect Immun. 2007. PMID: 17635860 Free PMC article.
-
Immunization with a Pseudomonas aeruginosa 1244 pilin provides O-antigen-specific protection.Clin Vaccine Immunol. 2008 Apr;15(4):590-7. doi: 10.1128/CVI.00476-07. Epub 2008 Feb 13. Clin Vaccine Immunol. 2008. PMID: 18272666 Free PMC article.
-
Type IV pilus glycosylation mediates resistance of Pseudomonas aeruginosa to opsonic activities of the pulmonary surfactant protein A.Infect Immun. 2015 Apr;83(4):1339-46. doi: 10.1128/IAI.02874-14. Epub 2015 Jan 20. Infect Immun. 2015. PMID: 25605768 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources